Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study
- PMID: 27406103
- DOI: 10.1161/STROKEAHA.116.013952
Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study
Erratum in
-
Correction to: Remote Intracerebral Hemorrhage After Intravenous Thrombolysis: Results From a Multicenter Study.Stroke. 2017 Oct;48(10):e320. doi: 10.1161/STR.0000000000000151. Stroke. 2017. PMID: 28947601 No abstract available.
Abstract
Background and purpose: Remote parenchymal hemorrhage (rPH) after intravenous thrombolysis with recombinant tissue-type plasminogen activator may be associated with cerebral amyloid angiopathy, although supportive data are limited. We aimed to investigate risk factors of rPH after intravenous thrombolysis with recombinant tissue-type plasminogen activator.
Methods: This is an observational study of patients with ischemic stroke who were treated with intravenous thrombolysis with recombinant tissue-type plasminogen activator and were included in a multicenter prospective registry. rPH was defined as any extraischemic hemorrhage detected in the follow-up computed tomography. We collected demographic, clinical, laboratory, radiological, and outcome variables. In the subset of patients who underwent a magnetic resonance imaging examination, we evaluated the distribution and burden of cerebral microbleeds, cortical superficial siderosis, leukoaraiosis, and recent silent ischemia in regions anatomically unrelated to the ischemic lesion that caused the initial symptoms. We compared patients with rPH with those without rPH or parenchymal hemorrhage. Independent risk factors for rPH were obtained by multivariable logistic regression analyses.
Results: We evaluated 992 patients (mean age, 74.0±12.6 years; 52.9% were men), and 408 (41%) of them underwent a magnetic resonance imaging. Twenty-six patients (2.6%) had a rPH, 8 (0.8%) had both rPH and PH, 58 (5.8%) had PH, and 900 (90.7%) had no bleeding complication. Lobar cerebral microbleeds (odds ratio, 8.0; 95% confidence interval, 2.3-27.2) and recent silent ischemia (odds ratio, 4.8; 95% confidence interval, 1.6-14.1) increased the risk of rPH.
Conclusions: The occurrence of rPH after intravenous thrombolysis with recombinant tissue-type plasminogen activator in patients with ischemic stroke is associated with lobar cerebral microbleeds and multiple ischemic lesions in different regions.
Keywords: amyloid; cerebral amyloid angiopathy; cerebral hemorrhage; stroke; thrombolytic therapy.
© 2016 American Heart Association, Inc.
Similar articles
-
Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis.PLoS One. 2017 Jun 22;12(6):e0178284. doi: 10.1371/journal.pone.0178284. eCollection 2017. PLoS One. 2017. PMID: 28640874 Free PMC article.
-
Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?Int J Stroke. 2016 Oct;11(7):783-90. doi: 10.1177/1747493016654289. Epub 2016 Jun 16. Int J Stroke. 2016. PMID: 27312681
-
Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.Stroke. 2014 Jun;45(6):1657-63. doi: 10.1161/STROKEAHA.114.004923. Epub 2014 May 1. Stroke. 2014. PMID: 24788971 Clinical Trial.
-
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22868870 Review.
-
Thrombolysis in dementia patients with acute stroke: is it justified?Neurol Sci. 2017 Jan;38(1):27-31. doi: 10.1007/s10072-016-2725-4. Epub 2016 Oct 3. Neurol Sci. 2017. PMID: 27699498 Review.
Cited by
-
Early administration of pyrrolidine dithiocarbamate extends the therapeutic time window of tissue plasminogen activator in a male rat model of embolic stroke.J Neurosci Res. 2018 Mar;96(3):449-458. doi: 10.1002/jnr.24186. Epub 2017 Oct 4. J Neurosci Res. 2018. PMID: 28976017 Free PMC article.
-
Exploring the Impact of Cerebral Microbleeds on Stroke Management.Neurol Int. 2023 Feb 1;15(1):188-224. doi: 10.3390/neurolint15010014. Neurol Int. 2023. PMID: 36810469 Free PMC article. Review.
-
Suitability of Thrombolysis for Patients With Acute Ischemic Stroke Complicated With Trousseau Syndrome.Front Neurosci. 2020 Jun 12;14:481. doi: 10.3389/fnins.2020.00481. eCollection 2020. Front Neurosci. 2020. PMID: 32595439 Free PMC article.
-
The Risk of Symptomatic Intracranial Hemorrhage after Thrombolysis for Acute Stroke: Current Concepts and Perspectives.Ann Indian Acad Neurol. 2019 Jul-Sep;22(3):336-340. doi: 10.4103/aian.AIAN_323_18. Ann Indian Acad Neurol. 2019. PMID: 31359953 Free PMC article.
-
Risk factors are different for deep and lobar remote hemorrhages after intravenous thrombolysis.PLoS One. 2017 Jun 22;12(6):e0178284. doi: 10.1371/journal.pone.0178284. eCollection 2017. PLoS One. 2017. PMID: 28640874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical